BioSpace News Archive

Business

D’Amore Healthcare Names Jennifer Carpenter Chief Operations Officer

D’Amore Healthcare is excited to announce that Jennifer Carpenter has accepted the position of Chief Operations Officer. Jennifer brings to bear 13 years of experience in behavioral health, including a very productive period at the Pat Moore Foundation in Costa Mesa, CA.

December 16, 2019
·
2 min read
Pharm Country

Integra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

A live audio webcast of the presentation will be available on the Investors section of the company’s website at www.integralife.com.

December 16, 2019
·
2 min read
FDA

Prevail Therapeutics Announces FDA Orphan Drug Designation Granted to PR006 for the Treatment of Patients with Frontotemporal Dementia with a GRN Mutation

PR006 is designed to increase progranulin levels in FTD-GRN patients by delivering a healthy GRN gene using an AAV9 vector.

December 16, 2019
·
4 min read
FDA

Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation

MDS is a group of bone marrow disorders that can cause severe complications, such as infections and uncontrolled bleeding, and can lead to the development of acute myelogenous leukemia

December 16, 2019
·
10 min read
Business

Genesis HealthCare’s ACO Adds Nearly 200 New Unaffiliated Facilities

LTC ACO is a wholly-owned subsidiary of Genesis and the only post-acute care sponsored Accountable Care Organization (ACO) in the nation.

December 16, 2019
·
3 min read
Biotech Beach

Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain

HTX-011 is a dual-acting, fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam in a proprietary Biochronomer® polymer.

December 16, 2019
·
5 min read
Kane Biotech Launches Consumer Product Test for an Innovative Shampoo Containing its Patented Anti-Biofilm Technology

Recent research has indicated that the persistence of microbial biofilm may be linked with aggravating the symptoms associated with atopic dermatitis, seborrheic dermatitis (also known as eczema) and dandruff.

December 16, 2019
·
4 min read
Deals

Lilly Announces 15 Percent Dividend Increase - Dec. 16, 2019

The board of directors of Eli Lilly and Company announced a 15 percent increase in its quarterly dividend.

December 16, 2019
·
1 min read
Deals

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) - Dec. 16, 2019

Arrowhead Pharmaceuticals Inc. announced that as an inducement to entering into employment with the Company, on December 6, 2019, the Compensation Committee of the Board of Directors approved “inducement” grants to 21 new employees under Rule 5635 of the NASDAQ Marketplace Rules.

December 16, 2019
·
2 min read
Drug Development

First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar® Gel (Repository Corticotropin Injection) for Severe Keratitis

The Phase 4 clinical study is titled “A Multicenter, Open-Label Study to Assess the Efficacy and Safety of Acthar Gel in Subjects with Severe Keratitis.”

December 16, 2019
·
10 min read